BindingDB logo
myBDB logout
Compile Data Set for Download or QSAR

Found 516 hits of ec50 data for polymerid = 8886,4373   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kJ/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
5'-AMP-activated protein kinase subunit beta-1


(Homo sapiens (Human))
BDBM50195477
PNG
(CHEMBL3979403)
Show SMILES COc1cc(on1)C(O)=C1C(=O)Nc2cc(Cl)c(cc12)-c1ccc2n(C)ccc2c1
Show InChI InChI=1S/C22H16ClN3O4/c1-26-6-5-12-7-11(3-4-17(12)26)13-8-14-16(9-15(13)23)24-22(28)20(14)21(27)18-10-19(29-2)25-30-18/h3-10,27H,1-2H3,(H,24,28)/b21-20+
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/an/an/a 0.700n/an/an/an/a



Pfizer Inc.

Curated by ChEMBL


Assay Description
Activation of recombinant human His-tagged AMPK alpha2 (2 to 552 residues)/beta1 (2 to 270 residues)/gamma2 (2 to 569 residues) expressed in baculovi...


Bioorg Med Chem Lett 26: 5139-5148 (2016)


Article DOI: 10.1016/j.bmcl.2016.09.065
BindingDB Entry DOI: 10.7270/Q25M67PH
More data for this
Ligand-Target Pair
AMPK subunit alpha-2


(Homo sapiens (Human))
BDBM244234
PNG
(US9428501, 58)
Show SMILES CCOc1cnc(CN2CCC(CC2)n2cc3cc(ccc3n2)C(=O)N2CCN(Cc3ccc(cc3)C(F)(F)F)CC2)cn1
Show InChI InChI=1S/C32H36F3N7O2/c1-2-44-30-19-36-27(18-37-30)22-39-11-9-28(10-12-39)42-21-25-17-24(5-8-29(25)38-42)31(43)41-15-13-40(14-16-41)20-23-3-6-26(7-4-23)32(33,34)35/h3-8,17-19,21,28H,2,9-16,20,22H2,1H3
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 0.860n/an/an/a37



Astellas Pharma Inc.

US Patent


Assay Description
In order to make MDA-MB-453 cell become 15000 cells per well, each 36 μl was seeded in Leibovitz's L-15 medium including 10% fetal bovine serum (m...


US Patent US9428501 (2016)


BindingDB Entry DOI: 10.7270/Q28051JK
More data for this
Ligand-Target Pair
AMPK subunit alpha-2


(Homo sapiens (Human))
BDBM244236
PNG
(US9428501, 69)
Show SMILES CCOc1cnc(CN2CCC(CC2)c2ccc3cc(C(=O)N4CCN(Cc5ccc(cc5)C#N)CC4)n(C)c3c2)cn1
Show InChI InChI=1S/C34H39N7O2/c1-3-43-33-22-36-30(21-37-33)24-39-12-10-27(11-13-39)28-8-9-29-19-32(38(2)31(29)18-28)34(42)41-16-14-40(15-17-41)23-26-6-4-25(20-35)5-7-26/h4-9,18-19,21-22,27H,3,10-17,23-24H2,1-2H3
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 1.80n/an/an/a37



Astellas Pharma Inc.

US Patent


Assay Description
In order to make MDA-MB-453 cell become 15000 cells per well, each 36 μl was seeded in Leibovitz's L-15 medium including 10% fetal bovine serum (m...


US Patent US9428501 (2016)


BindingDB Entry DOI: 10.7270/Q28051JK
More data for this
Ligand-Target Pair
AMPK subunit alpha-2


(Homo sapiens (Human))
BDBM244233
PNG
(US9428501, 57)
Show SMILES COc1ccc(CN2CCC(CC2)n2cc3cc(ccc3n2)C(=O)N2CCN(Cc3ccc(cc3)C(F)(F)F)CC2)cn1
Show InChI InChI=1S/C32H35F3N6O2/c1-43-30-9-4-24(19-36-30)21-38-12-10-28(11-13-38)41-22-26-18-25(5-8-29(26)37-41)31(42)40-16-14-39(15-17-40)20-23-2-6-27(7-3-23)32(33,34)35/h2-9,18-19,22,28H,10-17,20-21H2,1H3
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 1.80n/an/an/a37



Astellas Pharma Inc.

US Patent


Assay Description
In order to make MDA-MB-453 cell become 15000 cells per well, each 36 μl was seeded in Leibovitz's L-15 medium including 10% fetal bovine serum (m...


US Patent US9428501 (2016)


BindingDB Entry DOI: 10.7270/Q28051JK
More data for this
Ligand-Target Pair
AMPK subunit alpha-2


(Homo sapiens (Human))
BDBM244235
PNG
(US9428501, 66)
Show SMILES CCOc1cnc(CN2CCC(CC2)c2ccc3n(C)c(cc3c2)C(=O)N2CCN(Cc3ccc(cc3)C#N)CC2)cn1
Show InChI InChI=1S/C34H39N7O2/c1-3-43-33-22-36-30(21-37-33)24-39-12-10-27(11-13-39)28-8-9-31-29(18-28)19-32(38(31)2)34(42)41-16-14-40(15-17-41)23-26-6-4-25(20-35)5-7-26/h4-9,18-19,21-22,27H,3,10-17,23-24H2,1-2H3
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 2.80n/an/an/a37



Astellas Pharma Inc.

US Patent


Assay Description
In order to make MDA-MB-453 cell become 15000 cells per well, each 36 μl was seeded in Leibovitz's L-15 medium including 10% fetal bovine serum (m...


US Patent US9428501 (2016)


BindingDB Entry DOI: 10.7270/Q28051JK
More data for this
Ligand-Target Pair
AMPK subunit alpha-2


(Homo sapiens (Human))
BDBM244223
PNG
(US9428501, 18)
Show SMILES COc1ccc(CN2CCC(CC2)c2ccc3nc(C(=O)N4CCN(Cc5ccc(cc5)C(F)(F)F)CC4)n(C)c3c2)cn1
Show InChI InChI=1S/C33H37F3N6O2/c1-39-29-19-26(25-11-13-40(14-12-25)22-24-5-10-30(44-2)37-20-24)6-9-28(29)38-31(39)32(43)42-17-15-41(16-18-42)21-23-3-7-27(8-4-23)33(34,35)36/h3-10,19-20,25H,11-18,21-22H2,1-2H3
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 3n/an/an/a37



Astellas Pharma Inc.

US Patent


Assay Description
In order to make MDA-MB-453 cell become 15000 cells per well, each 36 μl was seeded in Leibovitz's L-15 medium including 10% fetal bovine serum (m...


US Patent US9428501 (2016)


BindingDB Entry DOI: 10.7270/Q28051JK
More data for this
Ligand-Target Pair
AMPK subunit alpha-2


(Homo sapiens (Human))
BDBM244237
PNG
(US9428501, 79)
Show SMILES COc1cnc(CN2CCC(CC2)c2ccc3n(C)c(cc3c2)C(=O)N2CCN(Cc3ccc(cc3)C#N)CC2)cn1
Show InChI InChI=1S/C33H37N7O2/c1-37-30-8-7-27(26-9-11-38(12-10-26)23-29-20-36-32(42-2)21-35-29)17-28(30)18-31(37)33(41)40-15-13-39(14-16-40)22-25-5-3-24(19-34)4-6-25/h3-8,17-18,20-21,26H,9-16,22-23H2,1-2H3
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 3.30n/an/an/a37



Astellas Pharma Inc.

US Patent


Assay Description
In order to make MDA-MB-453 cell become 15000 cells per well, each 36 μl was seeded in Leibovitz's L-15 medium including 10% fetal bovine serum (m...


US Patent US9428501 (2016)


BindingDB Entry DOI: 10.7270/Q28051JK
More data for this
Ligand-Target Pair
AMPK subunit alpha-2


(Homo sapiens (Human))
BDBM244226
PNG
(US9428501, 35)
Show SMILES COc1ccc(CN2CCC(CC2)c2ccc3nc(cn3c2)C(=O)N2CCN(Cc3ccc(cc3)C(F)(F)F)CC2)cn1
Show InChI InChI=1S/C32H35F3N6O2/c1-43-30-9-4-24(18-36-30)20-38-12-10-25(11-13-38)26-5-8-29-37-28(22-41(29)21-26)31(42)40-16-14-39(15-17-40)19-23-2-6-27(7-3-23)32(33,34)35/h2-9,18,21-22,25H,10-17,19-20H2,1H3
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 3.60n/an/an/a37



Astellas Pharma Inc.

US Patent


Assay Description
In order to make MDA-MB-453 cell become 15000 cells per well, each 36 μl was seeded in Leibovitz's L-15 medium including 10% fetal bovine serum (m...


US Patent US9428501 (2016)


BindingDB Entry DOI: 10.7270/Q28051JK
More data for this
Ligand-Target Pair
AMPK subunit alpha-2


(Homo sapiens (Human))
BDBM244227
PNG
(US9428501, 36)
Show SMILES COc1ccc(CN2CCC(CC2)c2ccn3cc(nc3c2)C(=O)N2CCN(Cc3ccc(cc3)C(F)(F)F)CC2)cn1
Show InChI InChI=1S/C32H35F3N6O2/c1-43-30-7-4-24(19-36-30)21-38-11-8-25(9-12-38)26-10-13-41-22-28(37-29(41)18-26)31(42)40-16-14-39(15-17-40)20-23-2-5-27(6-3-23)32(33,34)35/h2-7,10,13,18-19,22,25H,8-9,11-12,14-17,20-21H2,1H3
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 5.10n/an/an/a37



Astellas Pharma Inc.

US Patent


Assay Description
In order to make MDA-MB-453 cell become 15000 cells per well, each 36 μl was seeded in Leibovitz's L-15 medium including 10% fetal bovine serum (m...


US Patent US9428501 (2016)


BindingDB Entry DOI: 10.7270/Q28051JK
More data for this
Ligand-Target Pair
AMPK subunit alpha-2


(Homo sapiens (Human))
BDBM244230
PNG
(US9428501, 44)
Show SMILES COc1ccc(CN2CCC(CC2)c2cc3cc(C(=O)N4CCN(Cc5ccc(cc5)C(F)(F)F)CC4)n(C)c3cn2)cn1
Show InChI InChI=1S/C33H37F3N6O2/c1-39-29(32(43)42-15-13-41(14-16-42)21-23-3-6-27(7-4-23)33(34,35)36)18-26-17-28(37-20-30(26)39)25-9-11-40(12-10-25)22-24-5-8-31(44-2)38-19-24/h3-8,17-20,25H,9-16,21-22H2,1-2H3
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 5.20n/an/an/a37



Astellas Pharma Inc.

US Patent


Assay Description
In order to make MDA-MB-453 cell become 15000 cells per well, each 36 μl was seeded in Leibovitz's L-15 medium including 10% fetal bovine serum (m...


US Patent US9428501 (2016)


BindingDB Entry DOI: 10.7270/Q28051JK
More data for this
Ligand-Target Pair
AMPK subunit alpha-2


(Homo sapiens (Human))
BDBM244231
PNG
(US9428501, 49)
Show SMILES COc1ccc(CN2CCC(CC2)c2ccn3nc(cc3c2)C(=O)N2CCN(Cc3ccc(cc3)C(F)(F)F)CC2)cn1
Show InChI InChI=1S/C32H35F3N6O2/c1-43-30-7-4-24(20-36-30)22-38-11-8-25(9-12-38)26-10-13-41-28(18-26)19-29(37-41)31(42)40-16-14-39(15-17-40)21-23-2-5-27(6-3-23)32(33,34)35/h2-7,10,13,18-20,25H,8-9,11-12,14-17,21-22H2,1H3
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 6.5n/an/an/a37



Astellas Pharma Inc.

US Patent


Assay Description
In order to make MDA-MB-453 cell become 15000 cells per well, each 36 μl was seeded in Leibovitz's L-15 medium including 10% fetal bovine serum (m...


US Patent US9428501 (2016)


BindingDB Entry DOI: 10.7270/Q28051JK
More data for this
Ligand-Target Pair
AMPK subunit alpha-2


(Homo sapiens (Human))
BDBM244220
PNG
(US9428501, 7)
Show SMILES COc1cnc(CN2CCC(CC2)c2ccc3[nH]c(nc3c2)C(=O)N2CCN(Cc3ccc(cc3)C(F)(F)F)CC2)cn1
Show InChI InChI=1S/C31H34F3N7O2/c1-43-28-18-35-25(17-36-28)20-39-10-8-22(9-11-39)23-4-7-26-27(16-23)38-29(37-26)30(42)41-14-12-40(13-15-41)19-21-2-5-24(6-3-21)31(32,33)34/h2-7,16-18,22H,8-15,19-20H2,1H3,(H,37,38)
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 8.30n/an/an/a37



Astellas Pharma Inc.

US Patent


Assay Description
In order to make MDA-MB-453 cell become 15000 cells per well, each 36 μl was seeded in Leibovitz's L-15 medium including 10% fetal bovine serum (m...


US Patent US9428501 (2016)


BindingDB Entry DOI: 10.7270/Q28051JK
More data for this
Ligand-Target Pair
AMPK subunit alpha-2


(Homo sapiens (Human))
BDBM244228
PNG
(US9428501, 37)
Show SMILES COc1ccc(CN2CCC(CC2)c2ccc3nc([nH]c3c2)C(=O)N2CCN(Cc3ccc4OC(F)(F)Oc4c3)CC2)cn1
Show InChI InChI=1S/C32H34F2N6O4/c1-42-29-7-3-22(18-35-29)20-38-10-8-23(9-11-38)24-4-5-25-26(17-24)37-30(36-25)31(41)40-14-12-39(13-15-40)19-21-2-6-27-28(16-21)44-32(33,34)43-27/h2-7,16-18,23H,8-15,19-20H2,1H3,(H,36,37)
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 10n/an/an/a37



Astellas Pharma Inc.

US Patent


Assay Description
In order to make MDA-MB-453 cell become 15000 cells per well, each 36 μl was seeded in Leibovitz's L-15 medium including 10% fetal bovine serum (m...


US Patent US9428501 (2016)


BindingDB Entry DOI: 10.7270/Q28051JK
More data for this
Ligand-Target Pair
AMPK subunit alpha-2


(Homo sapiens (Human))
BDBM244224
PNG
(US9428501, 19)
Show SMILES COc1ccc(CN2CCC(CC2)c2ccc3n(C)c(nc3c2)C(=O)N2CCN(Cc3ccc(cc3)C(F)(F)F)CC2)cn1
Show InChI InChI=1S/C33H37F3N6O2/c1-39-29-9-6-26(25-11-13-40(14-12-25)22-24-5-10-30(44-2)37-20-24)19-28(29)38-31(39)32(43)42-17-15-41(16-18-42)21-23-3-7-27(8-4-23)33(34,35)36/h3-10,19-20,25H,11-18,21-22H2,1-2H3
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 10n/an/an/a37



Astellas Pharma Inc.

US Patent


Assay Description
In order to make MDA-MB-453 cell become 15000 cells per well, each 36 μl was seeded in Leibovitz's L-15 medium including 10% fetal bovine serum (m...


US Patent US9428501 (2016)


BindingDB Entry DOI: 10.7270/Q28051JK
More data for this
Ligand-Target Pair
AMPK subunit alpha-2


(Homo sapiens (Human))
BDBM244221
PNG
(US9428501, 8)
Show SMILES COc1cnc(CN2CCC(CC2)c2ccc3nc([nH]c3c2)C(=O)N2CCN(Cc3ccc(cc3)C(F)(F)F)CC2)cn1
Show InChI InChI=1S/C31H34F3N7O2/c1-43-28-18-35-25(17-36-28)20-39-10-8-22(9-11-39)23-4-7-26-27(16-23)38-29(37-26)30(42)41-14-12-40(13-15-41)19-21-2-5-24(6-3-21)31(32,33)34/h2-7,16-18,22H,8-15,19-20H2,1H3,(H,37,38)
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 13n/an/an/a37



Astellas Pharma Inc.

US Patent


Assay Description
In order to make MDA-MB-453 cell become 15000 cells per well, each 36 μl was seeded in Leibovitz's L-15 medium including 10% fetal bovine serum (m...


US Patent US9428501 (2016)


BindingDB Entry DOI: 10.7270/Q28051JK
More data for this
Ligand-Target Pair
AMPK subunit alpha-2


(Homo sapiens (Human))
BDBM244229
PNG
(US9428501, 38)
Show SMILES COc1ccc(CN2CCC(CC2)c2ccc3nc([nH]c3c2)C(=O)N2CCN(Cc3ccc(cc3F)C(F)(F)F)CC2)cn1
Show InChI InChI=1S/C32H34F4N6O2/c1-44-29-7-2-21(18-37-29)19-40-10-8-22(9-11-40)23-4-6-27-28(16-23)39-30(38-27)31(43)42-14-12-41(13-15-42)20-24-3-5-25(17-26(24)33)32(34,35)36/h2-7,16-18,22H,8-15,19-20H2,1H3,(H,38,39)
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 13n/an/an/a37



Astellas Pharma Inc.

US Patent


Assay Description
In order to make MDA-MB-453 cell become 15000 cells per well, each 36 μl was seeded in Leibovitz's L-15 medium including 10% fetal bovine serum (m...


US Patent US9428501 (2016)


BindingDB Entry DOI: 10.7270/Q28051JK
More data for this
Ligand-Target Pair
AMPK subunit alpha-2


(Homo sapiens (Human))
BDBM244232
PNG
(US9428501, 50)
Show SMILES COc1cnc(CN2CCC(CC2)c2ccn3nc(cc3c2)C(=O)N2CCN(Cc3ccc(cc3)C(F)(F)F)CC2)cn1
Show InChI InChI=1S/C31H34F3N7O2/c1-43-29-19-35-26(18-36-29)21-38-9-6-23(7-10-38)24-8-11-41-27(16-24)17-28(37-41)30(42)40-14-12-39(13-15-40)20-22-2-4-25(5-3-22)31(32,33)34/h2-5,8,11,16-19,23H,6-7,9-10,12-15,20-21H2,1H3
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 14n/an/an/a37



Astellas Pharma Inc.

US Patent


Assay Description
In order to make MDA-MB-453 cell become 15000 cells per well, each 36 μl was seeded in Leibovitz's L-15 medium including 10% fetal bovine serum (m...


US Patent US9428501 (2016)


BindingDB Entry DOI: 10.7270/Q28051JK
More data for this
Ligand-Target Pair
AMPK subunit alpha-2


(Homo sapiens (Human))
BDBM244225
PNG
(US9428501, 23)
Show SMILES COc1ccc(CN2CCC(CC2)c2ccc3nc([nH]c3c2)C(=O)N2CCN(Cc3ccc(cc3)C#N)CC2)cn1
Show InChI InChI=1S/C32H35N7O2/c1-41-30-9-6-25(20-34-30)22-37-12-10-26(11-13-37)27-7-8-28-29(18-27)36-31(35-28)32(40)39-16-14-38(15-17-39)21-24-4-2-23(19-33)3-5-24/h2-9,18,20,26H,10-17,21-22H2,1H3,(H,35,36)
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 19n/an/an/a37



Astellas Pharma Inc.

US Patent


Assay Description
In order to make MDA-MB-453 cell become 15000 cells per well, each 36 μl was seeded in Leibovitz's L-15 medium including 10% fetal bovine serum (m...


US Patent US9428501 (2016)


BindingDB Entry DOI: 10.7270/Q28051JK
More data for this
Ligand-Target Pair
AMPK subunit alpha-2


(Homo sapiens (Human))
BDBM244219
PNG
(US9428501, 1)
Show SMILES COc1ccc(CN2CCC(CC2)c2ccc3[nH]c(nc3c2)C(=O)N2CCN(Cc3ccc(cc3)C(F)(F)F)CC2)cn1
Show InChI InChI=1S/C32H35F3N6O2/c1-43-29-9-4-23(19-36-29)21-39-12-10-24(11-13-39)25-5-8-27-28(18-25)38-30(37-27)31(42)41-16-14-40(15-17-41)20-22-2-6-26(7-3-22)32(33,34)35/h2-9,18-19,24H,10-17,20-21H2,1H3,(H,37,38)
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 24n/an/an/a37



Astellas Pharma Inc.

US Patent


Assay Description
In order to make MDA-MB-453 cell become 15000 cells per well, each 36 μl was seeded in Leibovitz's L-15 medium including 10% fetal bovine serum (m...


US Patent US9428501 (2016)


BindingDB Entry DOI: 10.7270/Q28051JK
More data for this
Ligand-Target Pair
AMPK subunit alpha-2


(Homo sapiens (Human))
BDBM244222
PNG
(US9428501, 14)
Show SMILES COc1ccc(CN2CCC(CC2)c2ccc3nc([nH]c3c2)C(=O)N2CCN(Cc3ccc(cc3)C(F)(F)F)CC2)cc1
Show InChI InChI=1S/C33H36F3N5O2/c1-43-28-9-4-24(5-10-28)21-39-14-12-25(13-15-39)26-6-11-29-30(20-26)38-31(37-29)32(42)41-18-16-40(17-19-41)22-23-2-7-27(8-3-23)33(34,35)36/h2-11,20,25H,12-19,21-22H2,1H3,(H,37,38)
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 34n/an/an/a37



Astellas Pharma Inc.

US Patent


Assay Description
In order to make MDA-MB-453 cell become 15000 cells per well, each 36 μl was seeded in Leibovitz's L-15 medium including 10% fetal bovine serum (m...


US Patent US9428501 (2016)


BindingDB Entry DOI: 10.7270/Q28051JK
More data for this
Ligand-Target Pair
5'-AMP-activated protein kinase subunit beta-1


(Homo sapiens (Human))
BDBM50195479
PNG
(CHEMBL3950376)
Show SMILES OC(=O)c1c[nH]c2ccc(cc12)-c1ccc(cc1)-c1c(O)cccc1O
Show InChI InChI=1S/C21H15NO4/c23-18-2-1-3-19(24)20(18)13-6-4-12(5-7-13)14-8-9-17-15(10-14)16(11-22-17)21(25)26/h1-11,22-24H,(H,25,26)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/an/an/a<500n/an/an/an/a



Pfizer Inc.

Curated by ChEMBL


Assay Description
Activation of human recombinant AMPK beta1 expressed in African green monkey COS7 cells or baculovirus infected insect cells assessed as increase in ...


Bioorg Med Chem Lett 26: 5139-5148 (2016)


Article DOI: 10.1016/j.bmcl.2016.09.065
BindingDB Entry DOI: 10.7270/Q25M67PH
More data for this
Ligand-Target Pair
ampk


(Homo sapiens (Human))
BDBM327862
PNG
(N-(4-(4- cyanobenzyl)piperadin- 4-yl)-6-(4-(4- flu...)
Show SMILES Fc1ccc(CN2CCN(CC2)C(=O)c2ccc(cn2)C(=O)NC2CCN(Cc3ccc(cc3)C#N)CC2)cc1
Show InChI InChI=1S/C31H33FN6O2/c32-27-8-5-25(6-9-27)22-37-15-17-38(18-16-37)31(40)29-10-7-26(20-34-29)30(39)35-28-11-13-36(14-12-28)21-24-3-1-23(19-33)2-4-24/h1-10,20,28H,11-18,21-22H2,(H,35,39)
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a<500n/an/an/an/a



Rigel Pharmaceuticals, Inc.

US Patent


Assay Description
Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti...


US Patent US9663496 (2017)

More data for this
Ligand-Target Pair
ampk


(Homo sapiens (Human))
BDBM327868
PNG
(N-(1- (cyclohexanecarbonyl) piperidin-4-yl)-5-(4-...)
Show SMILES Fc1ccc(CN2CCN(CC2)C(=O)c2ccc(nc2)C(=O)NC2CCN(CC2)C(=O)C2CCCCC2)cc1
Show InChI InChI=1S/C30H38FN5O3/c31-25-9-6-22(7-10-25)21-34-16-18-36(19-17-34)30(39)24-8-11-27(32-20-24)28(37)33-26-12-14-35(15-13-26)29(38)23-4-2-1-3-5-23/h6-11,20,23,26H,1-5,12-19,21H2,(H,33,37)
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a<500n/an/an/an/a



Rigel Pharmaceuticals, Inc.

US Patent


Assay Description
Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti...


US Patent US9663496 (2017)

More data for this
Ligand-Target Pair
ampk


(Homo sapiens (Human))
BDBM327869
PNG
(N-(1-(benzoyl)piperidin- 4-yl)-5-(4-(4- fluorobenz...)
Show SMILES Fc1ccc(CN2CCN(CC2)C(=O)c2ccc(nc2)C(=O)NC2CCN(CC2)C(=O)c2ccccc2)cc1
Show InChI InChI=1S/C30H32FN5O3/c31-25-9-6-22(7-10-25)21-34-16-18-36(19-17-34)30(39)24-8-11-27(32-20-24)28(37)33-26-12-14-35(15-13-26)29(38)23-4-2-1-3-5-23/h1-11,20,26H,12-19,21H2,(H,33,37)
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a<500n/an/an/an/a



Rigel Pharmaceuticals, Inc.

US Patent


Assay Description
Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti...


US Patent US9663496 (2017)

More data for this
Ligand-Target Pair
ampk


(Homo sapiens (Human))
BDBM327870
PNG
(N-(1-(4-cyanobenzyl)- 1H-pyrazol-3-yl)-5-(4- (4- f...)
Show SMILES Fc1ccc(CN2CCN(CC2)C(=O)c2ccc(nc2)C(=O)Nc2ccn(Cc3ccc(cc3)C#N)n2)cc1
Show InChI InChI=1S/C29H26FN7O2/c30-25-8-5-22(6-9-25)19-35-13-15-36(16-14-35)29(39)24-7-10-26(32-18-24)28(38)33-27-11-12-37(34-27)20-23-3-1-21(17-31)2-4-23/h1-12,18H,13-16,19-20H2,(H,33,34,38)
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a<500n/an/an/an/a



Rigel Pharmaceuticals, Inc.

US Patent


Assay Description
Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti...


US Patent US9663496 (2017)

More data for this
Ligand-Target Pair
ampk


(Homo sapiens (Human))
BDBM327871
PNG
(N-(4-benzylphenyl)-5- (4-(4- fluorobenzyl)piperazi...)
Show SMILES Fc1ccc(CN2CCN(CC2)C(=O)c2ccc(nc2)C(=O)Nc2ccc(Cc3ccccc3)cc2)cc1
Show InChI InChI=1S/C31H29FN4O2/c32-27-11-6-25(7-12-27)22-35-16-18-36(19-17-35)31(38)26-10-15-29(33-21-26)30(37)34-28-13-8-24(9-14-28)20-23-4-2-1-3-5-23/h1-15,21H,16-20,22H2,(H,34,37)
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a<500n/an/an/an/a



Rigel Pharmaceuticals, Inc.

US Patent


Assay Description
Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti...


US Patent US9663496 (2017)

More data for this
Ligand-Target Pair
ampk


(Homo sapiens (Human))
BDBM327872
PNG
(5-(4-(4- fluorobenzyl)piperazine- 1-carbonyl-N-(4-...)
Show SMILES Fc1ccc(CN2CCN(CC2)C(=O)c2ccc(nc2)C(=O)Nc2ccc(cc2)-c2ccccc2)cc1
Show InChI InChI=1S/C30H27FN4O2/c31-26-11-6-22(7-12-26)21-34-16-18-35(19-17-34)30(37)25-10-15-28(32-20-25)29(36)33-27-13-8-24(9-14-27)23-4-2-1-3-5-23/h1-15,20H,16-19,21H2,(H,33,36)
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a<500n/an/an/an/a



Rigel Pharmaceuticals, Inc.

US Patent


Assay Description
Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti...


US Patent US9663496 (2017)

More data for this
Ligand-Target Pair
ampk


(Homo sapiens (Human))
BDBM327877
PNG
(5-(4-(4- fluorobenzyl)piperazine- 1-carbonyl)-N-(4...)
Show SMILES Fc1ccc(CN2CCN(CC2)C(=O)c2ccc(nc2)C(=O)Nc2ccc(Oc3ccccc3)cc2)cc1
Show InChI InChI=1S/C30H27FN4O3/c31-24-9-6-22(7-10-24)21-34-16-18-35(19-17-34)30(37)23-8-15-28(32-20-23)29(36)33-25-11-13-27(14-12-25)38-26-4-2-1-3-5-26/h1-15,20H,16-19,21H2,(H,33,36)
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a<500n/an/an/an/a



Rigel Pharmaceuticals, Inc.

US Patent


Assay Description
Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti...


US Patent US9663496 (2017)

More data for this
Ligand-Target Pair
ampk


(Homo sapiens (Human))
BDBM327879
PNG
(5-(4-(4- fluorobenzyl)piperazine- 1-carbonyl)-N-(1...)
Show SMILES CC(N1CCC(CC1)NC(=O)c1ccc(cn1)C(=O)N1CCN(Cc2ccc(F)cc2)CC1)c1ccccc1
Show InChI InChI=1S/C31H36FN5O2/c1-23(25-5-3-2-4-6-25)36-15-13-28(14-16-36)34-30(38)29-12-9-26(21-33-29)31(39)37-19-17-35(18-20-37)22-24-7-10-27(32)11-8-24/h2-12,21,23,28H,13-20,22H2,1H3,(H,34,38)
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a<500n/an/an/an/a



Rigel Pharmaceuticals, Inc.

US Patent


Assay Description
Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti...


US Patent US9663496 (2017)

More data for this
Ligand-Target Pair
ampk


(Homo sapiens (Human))
BDBM327882
PNG
(5-(4-(4- fluorobenzyl)piperazine- 1-carbonyl)-N-(3...)
Show SMILES Fc1ccc(CN2CCN(CC2)C(=O)c2ccc(nc2)C(=O)Nc2cccc(Oc3ccccc3)c2)cc1
Show InChI InChI=1S/C30H27FN4O3/c31-24-12-9-22(10-13-24)21-34-15-17-35(18-16-34)30(37)23-11-14-28(32-20-23)29(36)33-25-5-4-8-27(19-25)38-26-6-2-1-3-7-26/h1-14,19-20H,15-18,21H2,(H,33,36)
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a<500n/an/an/an/a



Rigel Pharmaceuticals, Inc.

US Patent


Assay Description
Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti...


US Patent US9663496 (2017)

More data for this
Ligand-Target Pair
ampk


(Homo sapiens (Human))
BDBM327883
PNG
((6-(3- (benzyloxy)phenyl) pyridin-3-yl)(4-(4- flu...)
Show SMILES Fc1ccc(CN2CCN(CC2)C(=O)c2ccc(nc2)-c2cccc(OCc3ccccc3)c2)cc1
Show InChI InChI=1S/C30H28FN3O2/c31-27-12-9-23(10-13-27)21-33-15-17-34(18-16-33)30(35)26-11-14-29(32-20-26)25-7-4-8-28(19-25)36-22-24-5-2-1-3-6-24/h1-14,19-20H,15-18,21-22H2
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a<500n/an/an/an/a



Rigel Pharmaceuticals, Inc.

US Patent


Assay Description
Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti...


US Patent US9663496 (2017)

More data for this
Ligand-Target Pair
ampk


(Homo sapiens (Human))
BDBM327884
PNG
(N-(1-(4-cyanobenzyl)- 1H-pyrazol-4-yl)-5-(4- (4- f...)
Show SMILES Fc1ccc(CN2CCN(CC2)C(=O)c2ccc(nc2)C(=O)Nc2cnn(Cc3ccc(cc3)C#N)c2)cc1
Show InChI InChI=1S/C29H26FN7O2/c30-25-8-5-22(6-9-25)18-35-11-13-36(14-12-35)29(39)24-7-10-27(32-16-24)28(38)34-26-17-33-37(20-26)19-23-3-1-21(15-31)2-4-23/h1-10,16-17,20H,11-14,18-19H2,(H,34,38)
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a<500n/an/an/an/a



Rigel Pharmaceuticals, Inc.

US Patent


Assay Description
Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti...


US Patent US9663496 (2017)

More data for this
Ligand-Target Pair
ampk


(Homo sapiens (Human))
BDBM327885
PNG
(N-(4-(4- cyanophenyl)phenyl)-5- (4-(4- fluorobenzy...)
Show SMILES Fc1ccc(CN2CCN(CC2)C(=O)c2ccc(nc2)C(=O)Nc2ccc(cc2)-c2ccc(cc2)C#N)cc1
Show InChI InChI=1S/C31H26FN5O2/c32-27-10-3-23(4-11-27)21-36-15-17-37(18-16-36)31(39)26-9-14-29(34-20-26)30(38)35-28-12-7-25(8-13-28)24-5-1-22(19-33)2-6-24/h1-14,20H,15-18,21H2,(H,35,38)
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a<500n/an/an/an/a



Rigel Pharmaceuticals, Inc.

US Patent


Assay Description
Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti...


US Patent US9663496 (2017)

More data for this
Ligand-Target Pair
ampk


(Homo sapiens (Human))
BDBM327886
PNG
(5-(4-(4- fluorobenzyl)piperazine- 1-carbonyl)-N-(4...)
Show SMILES Fc1ccc(CN2CCN(CC2)C(=O)c2ccc(nc2)C(=O)Nc2ccc(cc2)-c2ccc(cc2)C(F)(F)F)cc1
Show InChI InChI=1S/C31H26F4N4O2/c32-26-10-1-21(2-11-26)20-38-15-17-39(18-16-38)30(41)24-7-14-28(36-19-24)29(40)37-27-12-5-23(6-13-27)22-3-8-25(9-4-22)31(33,34)35/h1-14,19H,15-18,20H2,(H,37,40)
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a<500n/an/an/an/a



Rigel Pharmaceuticals, Inc.

US Patent


Assay Description
Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti...


US Patent US9663496 (2017)

More data for this
Ligand-Target Pair
ampk


(Homo sapiens (Human))
BDBM327887
PNG
(N-(4-benzoylphenyl)-5- (4-(4- fluorobenzyl)piperaz...)
Show SMILES Fc1ccc(CN2CCN(CC2)C(=O)c2ccc(nc2)C(=O)Nc2ccc(cc2)C(=O)c2ccccc2)cc1
Show InChI InChI=1S/C31H27FN4O3/c32-26-11-6-22(7-12-26)21-35-16-18-36(19-17-35)31(39)25-10-15-28(33-20-25)30(38)34-27-13-8-24(9-14-27)29(37)23-4-2-1-3-5-23/h1-15,20H,16-19,21H2,(H,34,38)
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a<500n/an/an/an/a



Rigel Pharmaceuticals, Inc.

US Patent


Assay Description
Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti...


US Patent US9663496 (2017)

More data for this
Ligand-Target Pair
ampk


(Homo sapiens (Human))
BDBM327892
PNG
(4-((2-(5-(4-(4- fluorobenzyl)piperazine- 1-carbony...)
Show SMILES Fc1ccc(CN2CCN(CC2)C(=O)c2ccc(nc2)N2CCC3(C2)CCN(Cc2ccc(cc2)C#N)CC3)cc1
Show InChI InChI=1S/C33H37FN6O/c34-30-8-5-28(6-9-30)24-38-17-19-39(20-18-38)32(41)29-7-10-31(36-22-29)40-16-13-33(25-40)11-14-37(15-12-33)23-27-3-1-26(21-35)2-4-27/h1-10,22H,11-20,23-25H2
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a<500n/an/an/an/a



Rigel Pharmaceuticals, Inc.

US Patent


Assay Description
Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti...


US Patent US9663496 (2017)

More data for this
Ligand-Target Pair
ampk


(Homo sapiens (Human))
BDBM327906
PNG
(N-(4-(4- cyanobenzylcarbamoyl) phenyl)-5-(4-(4- f...)
Show SMILES Fc1ccc(CN2CCN(CC2)C(=O)c2ccc(nc2)C(=O)Nc2ccc(cc2)C(=O)NCc2ccc(cc2)C#N)cc1
Show InChI InChI=1S/C33H29FN6O3/c34-28-10-5-25(6-11-28)22-39-15-17-40(18-16-39)33(43)27-9-14-30(36-21-27)32(42)38-29-12-7-26(8-13-29)31(41)37-20-24-3-1-23(19-35)2-4-24/h1-14,21H,15-18,20,22H2,(H,37,41)(H,38,42)
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a<500n/an/an/an/a



Rigel Pharmaceuticals, Inc.

US Patent


Assay Description
Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti...


US Patent US9663496 (2017)

More data for this
Ligand-Target Pair
ampk


(Homo sapiens (Human))
BDBM327908
PNG
(N-(1-(3,5- difluorobenzyl)piperidin- 4-yl)-5-(4-(4...)
Show SMILES Fc1ccc(CN2CCN(CC2)C(=O)c2ccc(nc2)C(=O)NC2CCN(Cc3cc(F)cc(F)c3)CC2)cc1
Show InChI InChI=1S/C30H32F3N5O2/c31-24-4-1-21(2-5-24)19-37-11-13-38(14-12-37)30(40)23-3-6-28(34-18-23)29(39)35-27-7-9-36(10-8-27)20-22-15-25(32)17-26(33)16-22/h1-6,15-18,27H,7-14,19-20H2,(H,35,39)
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a<500n/an/an/an/a



Rigel Pharmaceuticals, Inc.

US Patent


Assay Description
Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti...


US Patent US9663496 (2017)

More data for this
Ligand-Target Pair
ampk


(Homo sapiens (Human))
BDBM327909
PNG
(5-(4-(4- fluorobenzyl)piperazine- 1-carbonyl)-N-(1...)
Show SMILES Cc1cc(CN2CCC(CC2)NC(=O)c2ccc(cn2)C(=O)N2CCN(Cc3ccc(F)cc3)CC2)ccc1F
Show InChI InChI=1S/C31H35F2N5O2/c1-22-18-24(4-8-28(22)33)21-36-12-10-27(11-13-36)35-30(39)29-9-5-25(19-34-29)31(40)38-16-14-37(15-17-38)20-23-2-6-26(32)7-3-23/h2-9,18-19,27H,10-17,20-21H2,1H3,(H,35,39)
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a<500n/an/an/an/a



Rigel Pharmaceuticals, Inc.

US Patent


Assay Description
Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti...


US Patent US9663496 (2017)

More data for this
Ligand-Target Pair
ampk


(Homo sapiens (Human))
BDBM327910
PNG
(N-(1-(4- chlorobenzyl)piperidin- 4-yl)-5-(4-(4- fl...)
Show SMILES COc1ccc(CC2CCC(CC2)NC(=O)c2ccc(cn2)C(=O)N2CCN(Cc3ccc(F)cc3)CC2)cc1
Show InChI InChI=1S/C32H37FN4O3/c1-40-29-13-6-24(7-14-29)20-23-4-11-28(12-5-23)35-31(38)30-15-8-26(21-34-30)32(39)37-18-16-36(17-19-37)22-25-2-9-27(33)10-3-25/h2-3,6-10,13-15,21,23,28H,4-5,11-12,16-20,22H2,1H3,(H,35,38)
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a<500n/an/an/an/a



Rigel Pharmaceuticals, Inc.

US Patent


Assay Description
Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti...


US Patent US9663496 (2017)

More data for this
Ligand-Target Pair
ampk


(Homo sapiens (Human))
BDBM327911
PNG
(N-(1-(4- chlorobenzyl)piperidin- 4-yl)-5-(4-(4- fl...)
Show SMILES Fc1ccc(CN2CCN(CC2)C(=O)c2ccc(nc2)C(=O)NC2CCN(Cc3ccc(Cl)cc3)CC2)cc1
Show InChI InChI=1S/C30H33ClFN5O2/c31-25-6-1-22(2-7-25)20-35-13-11-27(12-14-35)34-29(38)28-10-5-24(19-33-28)30(39)37-17-15-36(16-18-37)21-23-3-8-26(32)9-4-23/h1-10,19,27H,11-18,20-21H2,(H,34,38)
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a<500n/an/an/an/a



Rigel Pharmaceuticals, Inc.

US Patent


Assay Description
Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti...


US Patent US9663496 (2017)

More data for this
Ligand-Target Pair
ampk


(Homo sapiens (Human))
BDBM327912
PNG
(5-(4-(4- fluorobenzyl)piperazine- 1-carbonyl)-N-(4...)
Show SMILES Cc1ccc(Oc2ccc(NC(=O)c3ccc(cn3)C(=O)N3CCN(Cc4ccc(F)cc4)CC3)cc2)cc1
Show InChI InChI=1S/C31H29FN4O3/c1-22-2-11-27(12-3-22)39-28-13-9-26(10-14-28)34-30(37)29-15-6-24(20-33-29)31(38)36-18-16-35(17-19-36)21-23-4-7-25(32)8-5-23/h2-15,20H,16-19,21H2,1H3,(H,34,37)
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a<500n/an/an/an/a



Rigel Pharmaceuticals, Inc.

US Patent


Assay Description
Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti...


US Patent US9663496 (2017)

More data for this
Ligand-Target Pair
ampk


(Homo sapiens (Human))
BDBM327913
PNG
(5-(4-(4- fluorobenzyl)piperazine- 1-carbonyl)-N-(4...)
Show SMILES COc1ccc(Oc2ccc(NC(=O)c3ccc(cn3)C(=O)N3CCN(Cc4ccc(F)cc4)CC3)cc2)cc1
Show InChI InChI=1S/C31H29FN4O4/c1-39-26-11-13-28(14-12-26)40-27-9-7-25(8-10-27)34-30(37)29-15-4-23(20-33-29)31(38)36-18-16-35(17-19-36)21-22-2-5-24(32)6-3-22/h2-15,20H,16-19,21H2,1H3,(H,34,37)
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a<500n/an/an/an/a



Rigel Pharmaceuticals, Inc.

US Patent


Assay Description
Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti...


US Patent US9663496 (2017)

More data for this
Ligand-Target Pair
ampk


(Homo sapiens (Human))
BDBM327914
PNG
(5-(4-(4- fluorobenzyl)piperazine- 1-carbonyl)-N-(4...)
Show SMILES Fc1ccc(CN2CCN(CC2)C(=O)c2ccc(nc2)C(=O)Nc2ccc(Oc3cccc(F)c3)cc2)cc1
Show InChI InChI=1S/C30H26F2N4O3/c31-23-7-4-21(5-8-23)20-35-14-16-36(17-15-35)30(38)22-6-13-28(33-19-22)29(37)34-25-9-11-26(12-10-25)39-27-3-1-2-24(32)18-27/h1-13,18-19H,14-17,20H2,(H,34,37)
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a<500n/an/an/an/a



Rigel Pharmaceuticals, Inc.

US Patent


Assay Description
Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti...


US Patent US9663496 (2017)

More data for this
Ligand-Target Pair
ampk


(Homo sapiens (Human))
BDBM327915
PNG
(N-(4-(3- cyanophenoxy)phenyl)- 5-(4-(4- fluorobenz...)
Show SMILES Fc1ccc(CN2CCN(CC2)C(=O)c2ccc(nc2)C(=O)Nc2ccc(Oc3cccc(c3)C#N)cc2)cc1
Show InChI InChI=1S/C31H26FN5O3/c32-25-7-4-22(5-8-25)21-36-14-16-37(17-15-36)31(39)24-6-13-29(34-20-24)30(38)35-26-9-11-27(12-10-26)40-28-3-1-2-23(18-28)19-33/h1-13,18,20H,14-17,21H2,(H,35,38)
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a<500n/an/an/an/a



Rigel Pharmaceuticals, Inc.

US Patent


Assay Description
Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti...


US Patent US9663496 (2017)

More data for this
Ligand-Target Pair
ampk


(Homo sapiens (Human))
BDBM327916
PNG
(5-(4-(4- fluorobenzyl)piperazine- 1-carbonyl)-N-(4...)
Show SMILES COc1cccc(Oc2ccc(NC(=O)c3ccc(cn3)C(=O)N3CCN(Cc4ccc(F)cc4)CC3)cc2)c1
Show InChI InChI=1S/C31H29FN4O4/c1-39-27-3-2-4-28(19-27)40-26-12-10-25(11-13-26)34-30(37)29-14-7-23(20-33-29)31(38)36-17-15-35(16-18-36)21-22-5-8-24(32)9-6-22/h2-14,19-20H,15-18,21H2,1H3,(H,34,37)
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a<500n/an/an/an/a



Rigel Pharmaceuticals, Inc.

US Patent


Assay Description
Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti...


US Patent US9663496 (2017)

More data for this
Ligand-Target Pair
ampk


(Homo sapiens (Human))
BDBM327917
PNG
(5-(4-(4- fluorobenzyl)piperazine- 1-carbonyl)-N-(4...)
Show SMILES Cc1cccc(Oc2ccc(NC(=O)c3ccc(cn3)C(=O)N3CCN(Cc4ccc(F)cc4)CC3)cc2)c1
Show InChI InChI=1S/C31H29FN4O3/c1-22-3-2-4-28(19-22)39-27-12-10-26(11-13-27)34-30(37)29-14-7-24(20-33-29)31(38)36-17-15-35(16-18-36)21-23-5-8-25(32)9-6-23/h2-14,19-20H,15-18,21H2,1H3,(H,34,37)
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a<500n/an/an/an/a



Rigel Pharmaceuticals, Inc.

US Patent


Assay Description
Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti...


US Patent US9663496 (2017)

More data for this
Ligand-Target Pair
ampk


(Homo sapiens (Human))
BDBM327918
PNG
(N-(4-(4- cyanophenoxy)phenyl)- 5-(4-(4- fluorobenz...)
Show SMILES Fc1ccc(CN2CCN(CC2)C(=O)c2ccc(nc2)C(=O)Nc2ccc(Oc3ccc(cc3)C#N)cc2)cc1
Show InChI InChI=1S/C31H26FN5O3/c32-25-6-1-23(2-7-25)21-36-15-17-37(18-16-36)31(39)24-5-14-29(34-20-24)30(38)35-26-8-12-28(13-9-26)40-27-10-3-22(19-33)4-11-27/h1-14,20H,15-18,21H2,(H,35,38)
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a<500n/an/an/an/a



Rigel Pharmaceuticals, Inc.

US Patent


Assay Description
Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti...


US Patent US9663496 (2017)

More data for this
Ligand-Target Pair
ampk


(Homo sapiens (Human))
BDBM327919
PNG
(5-(4-(4- fluorobenzyl)piperazine- 1-carbonyl)-N-(4...)
Show SMILES Fc1ccc(CN2CCN(CC2)C(=O)c2ccc(nc2)C(=O)Nc2ccc(Oc3ccc(F)cc3)cc2)cc1
Show InChI InChI=1S/C30H26F2N4O3/c31-23-4-1-21(2-5-23)20-35-15-17-36(18-16-35)30(38)22-3-14-28(33-19-22)29(37)34-25-8-12-27(13-9-25)39-26-10-6-24(32)7-11-26/h1-14,19H,15-18,20H2,(H,34,37)
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a<500n/an/an/an/a



Rigel Pharmaceuticals, Inc.

US Patent


Assay Description
Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti...


US Patent US9663496 (2017)

More data for this
Ligand-Target Pair
ampk


(Homo sapiens (Human))
BDBM327920
PNG
(5-(4-(4- fluorobenzyl)piperazine- 1-carbonyl)-N-(4...)
Show SMILES Fc1ccc(CN2CCN(CC2)C(=O)c2ccc(nc2)C(=O)Nc2ccc(cc2)-c2cccnc2)cc1
Show InChI InChI=1S/C29H26FN5O2/c30-25-8-3-21(4-9-25)20-34-14-16-35(17-15-34)29(37)24-7-12-27(32-19-24)28(36)33-26-10-5-22(6-11-26)23-2-1-13-31-18-23/h1-13,18-19H,14-17,20H2,(H,33,36)
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a<500n/an/an/an/a



Rigel Pharmaceuticals, Inc.

US Patent


Assay Description
Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti...


US Patent US9663496 (2017)

More data for this
Ligand-Target Pair
Displayed 1 to 50 (of 516 total )  |  Next  |  Last  >>
Jump to: